Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: Relevance to amyotrophic lateral sclerosis

Journal of Neurochemistry

Volumn 91, Issue 2, 2004, Pages 404-412

  Okuno, Tatsusada ^a   Nakatsuji, Yuji ^a   Kumanogoh, Atsushi ^b   Koguchi, Ken ^a   Moriya, Masayuki ^a   Fujimura, Harutoshi ^a   Kikutani, Hitoshi ^b   Sakoda, Saburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; CD40; Cyclooxygenase; Gliosis; Inflammation

Indexed keywords

CD40 ANTIGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INDUCTION; GLIA CELL; GLIOSIS; IMMUNOSTIMULATION; MICROGLIA; MOTONEURON; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SPINAL CORD INJURY; TISSUE CULTURE; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIGENS, CD40; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEUROGLIA; NEURONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; SUPEROXIDE DISMUTASE; UP-REGULATION;

ANIMALIA; MUS MUSCULUS;

EID: 5444245787     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02727.x     Document Type: Article

References (52)

1. Abdel-Haq N., Hao H. N. and Lyman W. D. (1999) Cytokine regulation of CD40 expression in fetal human astrocyte cultures. J. Neuroimmunol. 101, 7-14.
2. Alexianu M. E., Kozovska M. and Appel S. H. (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57, 1282-1289.
3. Almer G., Vukosavic S., Romero N. and Przedborski S. (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415-2425.
4. Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A. P., Chen C. and Przedborski S. (2001) Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 49, 176-185.
5. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B. L., Pozzan T. and Volterra A. (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281-285.
6. Calingasan N. Y., Erdely H. A. and Altar C. A. (2002) Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol. Aging 23, 31-39.
7. Carriedo S. G., Yin H. Z. and Weiss J. H. (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16, 4069-4079.
8. D'Aversa T. G., Weidenheim K. M. and Berman J. W. (2002) CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am. J. Pathol. 160, 559-567.
9. Drachman D. B. and Rothstein J. D. (2000) Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann. Neurol. 48, 792-795.
10. Drachman D. B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S. and Rothstein J. D. (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52, 771-778.
11. Elliott J. L. (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95, 172-178.
12. Engelhardt J. I., Tajti J. and Appel S. H. (1993) Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50, 30-36.
13. Foy T. M., Aruffo A., Bajorath J., Buhlmann J. E. and Noelle R. J. (1996) Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14, 591-617.
14. Garlichs C. D., Geis T., Goppelt-Struebe M., Eskafi S., Schmidt A., Schulze-Koops H., Ludwig J., Daniel W. G. and Schmeisser A. (2002) Induction of cyclooxygenase-2 and enhanced release of prostaglandin E(2) and I(2) in human endothelial cells by engagement of CD40. Atherosclerosis 163, 9-16.
15. Gerritse K., Laman J. D., Noelle R. J., Aruffo A., Ledbetter J. A., Boersma W. J. and Claassen E. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl Acad. Sci. USA 93, 2499-2504.
16. Grewal I. S. and Flavell R. A. (1996) The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153, 85-106.
17. Grewal I. S., Foellmer H. G., Grewal K. D., Xu J., Hardardottir F., Baron J. L., Janeway C. A. Jr and Flavell R. A. (1996) Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273, 1864-1867.
18. Gurney M. E., Pu H., Chiu A. Y. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775.
19. Henkel J. S., Engelhardt J. I., Siklos L., Simpson E. P., Kim S. H., Pan T., Goodman J. C., Siddique T., Beers D. R. and Appel S. H. (2004) Presence of dendritic cells, MCP-1, and activated microglia/ macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221-235.
20. Hensley K., Fedynyshyn J., Ferrell S. et al. (2003) Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 14, 74-80.
21. Howard L. M., Miga A. J., Vanderlugt C. L., Dal Canto M. C., Laman J. D., Noelle R. J. and Miller S. D. (1999) Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103, 281-290.
22. Hunot S. and Hirsch E. C. (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53, S58-S60.
23. Jana M., Liu X., Koka S., Ghosh S., Petro T. M. and Pahan K. (2001) Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J. Biol. Chem. 276, 44527-44533.
24. Jana M., Dasgupta S., Liu X. and Pahan K. (2002) Regulation of tumor necrosis factor-alpha expression by CD40 ligation in BV-2 microglial cells. J. Neurochem. 80, 197-206.
25. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T. and Kikutani H. (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
26. Kawamata T., Akiyama H., Yamada T. and McGeer P. L. (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140, 691-707.
27. Kikuchi S., Shinpo K., Tsuji S., Yabe I., Niino M. and Tashiro K. (2003) Brefeldin A-induced neurotoxicity in cultured spinal cord neurons. J. Neurosci. Res. 71, 591-599.
28. Koguchi K., Nakatsuji Y., Nakayama K. and Sakoda S. (2002) Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27 (Kip1). Glia 37, 93-104.
29. Koguchi K., Nakatsuji Y., Okuno T., Sawada M. and Sakoda S. (2003) Microglial cell cycle-associated proteins control microglial proliferation in vivo and in vitro and are regulated by GM-CSF and density-dependent inhibition. J. Neurosci. Res. 74, 898-905.
30. Mach F., Schonbeck U., Sukhova G. K., Bourcier T., Bonnefoy J. Y., Pober J. S. and Libby P. (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl Acad. Sci. USA 94, 1931-1936.
31. Maihofher C., Probst-Cousin S., Bergmann M., Neuhuber W., Neundorfer B. and Heuss D. (2003) Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur. J. Neurosci. 18, 1527-1534.
32. McGeer E. G. and McGeer P. L. (1998) The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33, 371-378.
33. McGeer P. L. and McGeer E. G. (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26, 459-470.
34. Nagano S., Satoh M., Sumi H., Fujimura H., Tohyama C., Yanagihara T. and Sakoda S. (2001) Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur. J. Neurosci. 13, 1363-1370.
35. Nakatsuji Y. and Miller R. H. (1998) Homotypic cell contact-dependent inhibition of astrocyte proliferation. Glia 22, 379-389.
36. Nguyen V. T. and Benveniste E. N. (2000) Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J. Biol. Chem. 275, 23674-23684.
37. Nguyen M. D., Julien J. P. and Rivest S. (2001) Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann. Neurol. 50, 630-639.
38. Okuda Y., Sakoda S. and Yanagihara T. (1998) The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 87, 147-155.
39. Pompl P. N., Ho L., Bianchi M., McManus T., Qin W. and Pasinetti G. M. (2003) A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 17, 725-727.
40. Ridet J. L., Malhotra S. K., Privat A. and Gage F. H. (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577.
41. Rogers J., Webster S., Lue L. F., Brachova L., Civin W. H., Emmerling M., Shivers B., Walker D. and McGeer P. (1996) Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17, 681-686.
42. Rosen D. R., Siddique T., Patterson D. and et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
43. Schiffer D., Cordera S., Cavalla P. and Migheli A. (1996) Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 139, 27-33.
44. Siddique T. and Deng H. X. (1996) Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5, 1465-1470.
45. Tan J., Town T., Paris D., Mori T., Suo Z., Crawford F., Mattson M. P., Flavell R. A. and Mullan M. (1999) Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286, 2352-2355.
46. Tan J., Town T. and Mullan M. (2002a) CD40-CD40L interaction in Alzheimer's disease. Curr. Opin. Pharmacol. 2, 445-451.
47. Tan J., Town T., Crawford F., Mori T., DelleDonne A., Crescentini R., Obregon D., Flavell R. A. and Mullan M. J. (2002b) Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat. Neurosci. 5, 1288-1293.
48. Tan J., Town T., Mori T., Obregon D., Wu Y., DelleDonne A., Rojiani A., Crawford F., Flavell R. A. and Mullan M. (2002e) CD40 is expressed and functional on neuronal cells. EMBO J. 21, 643-652.
49. Togo T., Akiyama H., Kondo H., Ikeda K., Kato M., Iseki E. and Kosaka K. (2000) Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. Brain Res. 885, 117-121.
50. Wei R. and Jonakait G. M. (1999) Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 95, 8-18.
51. Yasojima K., Tourtellotte W. W., McGeer E. G. and McGeer P. L. (2001) Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 57, 952-956.
52. Zhang Y., Cao H. J., Graf B., Meekins H., Smith T. J. and Phipps R. P. (1998) CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J. Immunol. 160, 1053-1057.